Skip to main content
. Author manuscript; available in PMC: 2021 Jan 1.
Published in final edited form as: Gastroenterology. 2020 Aug 26;160(1):158–173.e10. doi: 10.1053/j.gastro.2020.08.041

Figure 5: KEGG pathway - changes and association with insulin rebound.

Figure 5:

Panel A: Shotgun metagenomics assessed metabolic pathways (KEGG modules) that were significantly changed by weight loss and maintained by the aFMT treatment, across lifestyle intervention groups. Panel B: Fold change of the same metabolic pathways as in ‘A’, comparing individuals with and without insulin rebound (defined as the median change between 6 and 14-months) among the aFMT+green Mediterranean group participants.